NCT06495021 How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.
| NCT ID | NCT06495021 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Geisinger Clinic |
| Condition | Pneumonia |
| Study Type | INTERVENTIONAL |
| Enrollment | 68 participants |
| Start Date | 2024-12-31 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 68 participants in total. It began in 2024-12-31 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is to see Osteopathic Manipulative Therapy, or OMT, can aid in treating patients being seen for respiratory illness and associated symptoms. The hypothesis is that the addition of OMT therapy, alongside other standard care (such as a medication), can help lessen patient symptoms sooner than just other treatment alone, and the duration of the condition will shorten as well.
Eligibility Criteria
Inclusion Criteria: * Patients being seen for respiratory illness symptoms at Geisinger 65-Forward Buckhorn, PA clinic for care. * Patients age of 65-100 * New diagnosis of upper respiratory illness, sinusitis, bronchitis, or pneumonia during outpatient visit. Exclusion Criteria: * Patients that have a healing fracture, including the spine, pelvis, shoulder, ribs, vertebrae, or extremities. * Patients actively receiving any type of cancer treatment * Patients with active or previously diagnosed liver disease.
Contact & Investigator
Margaret Moore, DO
PRINCIPAL INVESTIGATOR
Physician
Frequently Asked Questions
Who can join the NCT06495021 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, up to 100 Years, studying Pneumonia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06495021 currently recruiting?
Yes, NCT06495021 is actively recruiting participants. Contact the research team at Mmoore9@geisinger.edu for enrollment information.
Where is the NCT06495021 trial being conducted?
This trial is being conducted at Bloomsburg, United States.
Who is sponsoring the NCT06495021 clinical trial?
NCT06495021 is sponsored by Geisinger Clinic. The principal investigator is Margaret Moore, DO at Physician. The trial plans to enroll 68 participants.